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Background: Exercise training is effective in improving functional capacity and quality of life in patients with
coronary artery disease, but its effects on left ventricular systolic and diastolic function are controversial. Diastolic
dysfunction is a major determinant of adverse outcome after myocardial infarction and, contrary to systolic
function, no therapy or intervention has proved to significantly improve diastolic function. Data from animal studies
and from patients with diastolic heart failure has suggested that exercise training can have a positive effect on
diastolic function parameters.
This trial aims to evaluate if a structured exercise training program can improve resting left ventricular diastolic and
systolic function in patients who have had an acute myocardial infarction.
Methods/Design: This is a phase II, prospective, randomized, open-label, blinded-endpoint trial that will include at
least 96 consecutive patients who have had an acute myocardial infarction one month previously. Patients will be
randomized (1:1) to an exercise training program or a control group, receiving standard of care. At enrolment, and
at the end of the follow-up period, patients will be submitted to an echocardiography (with detailed assessment of
diastolic and systolic function using recent consensus guidelines), cardiopulmonary exercise testing, an anthropometric
assessment, blood testing, and clinical evaluation. Patients randomized to the intervention group will be submitted to
an eight-week outpatient exercise program, combining endurance and resistance training, for three sessions per week.
The primary endpoint will be the change in lateral E’ velocity immediately after the eight-week exercise training
program. Secondary endpoints will include other echocardiographic parameters of left ventricular diastolic and
systolic function, cardiac structure, metabolic and inflammation biomarkers (high-sensitivity C-reactive protein and
pro-BNP), functional capacity (peak oxygen consumption and anaerobic threshold) and anthropometric measurements.
Discussion: New strategies that can improve left ventricular diastolic function are clinically needed. This will be the first
trial to evaluate, in patients who have had an acute myocardial infarction, the effects of a structured program of exercise
training on diastolic and systolic function, assessed by novel echocardiographic parameters.
Trial registration: Registered with ClinicalTrials.gov (reference: NCT02224495) on 21 August 2014.
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Exercise training is effective in improving functional cap-
acity and quality of life in patients with coronary artery
disease [1,2]. It is known that exercise can improve several
cardiovascular and non-cardiovascular parameters, such
as glucose metabolism, skeletal muscle function, oxidative
stress, vascular function, pulmonary circulation, ischemia-
reperfusion lesion, and ventricular remodelling [3].
However, the effect of exercise training on left ven-
tricle systolic and diastolic function is still controversial
[4-6], especially after acute myocardial infarction (AMI),
where no longitudinal study has evaluated cardiac func-
tion using modern echocardiographic parameters, such as
those derived from tissue Doppler analysis. After AMI, the
effect of exercise training on diastolic function can be clin-
ically relevant because the majority of these patients have
diastolic dysfunction (DD) [4,7,8] and, most importantly,
because no therapy or intervention has been shown to sig-
nificantly improve diastolic function [9]. Data from animal
studies are encouraging, showing that endurance training
can improve myocardial relaxation and calcium homeosta-
sis by increasing the myocardial expression of SERCA2a
and phospholamban (PLB) [10,11]. Also, a recent study
evaluating patients with heart failure with preserved ejec-
tion fraction (also known as diastolic heart failure) has
shown that the combination of endurance and resistance
training can improve diastolic function parameters [12].
Finally, it is also still controversial whether systolic functionFigure 1 Design of the trial. In this prospective, randomized, open-label,
myocardial infarction one month previously will be randomized (1:1) to an
The primary endpoint will be the change in lateral E’ velocity between bascan be improved by exercise training [4,13,14]. Most of
these studies were small, lacked control groups, and evalu-
ated systolic function only by ejection fraction, which has
several limitations in the evaluation of global left ventricle
systolic function [15].
In this trial our aim is to assess, in patients who have
had an AMI, if a structured exercise training program
can improve resting left ventricular systolic and diastolic
function.Methods/Design
Trial design
In this prospective, randomized, open-label, blinded-
endpoint (“The Effect of Exercise Training on Car-
diac Structure and Function”) trial, patients who have
had an AMI one month previously will be randomized
(1:1) to be included in an eight-week duration exercise
training program or a control group, receiving standard of
care. Immediately before enrolment and at the end of the
follow-up period, patients will be submitted to a clinical
evaluation, detailed echocardiography, cardiopulmonary
exercise testing, and an anthropometric assessment, ac-
cording to the study design outlined in Figure 1. Because
the intervention is a structured exercise training program,
it is not possible to perform patient blinding. However, the
medical staff performing all the measurements will be
blinded to the type of intervention.blinded-endpoint trial consecutive patients who have had an acute
eight-week outpatient exercise training program or standard of care.
eline and follow-up.
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tion sequence based on a fixed block size of eight, gener-
ated with a computer random number generator.
Participants
Eligible patients will be consecutive individuals admitted
to Gaia Hospital Centre (a tertiary care hospital with a
reference population of 700,000 patients) after AMI,
including both ST-elevation and non-ST elevation
myocardial infarction. For inclusion in the study, we will
use the criteria in the universal definition of myocardial
infarction [16]. Table 1 details the study’s inclusion and
exclusion criteria.
Intervention: the exercise training program
Patients randomized to the exercise training group will be
included in an eight-week outpatient program, encompass-
ing three sessions per week, combining endurance and re-
sistance training. Each session will consist of 10 minutes of
warm up, 50 minutes of aerobic and resistance training,
and 10 minutes of cool down. During the eight weeks, en-
durance training (cycling in the first four weeks and tread-
mill in the remaining four weeks) of increasing intensity
will be performed. Training intensity will be individualized
to a target heart rate of 70 to 85% of the maximal heart
rate achieved in the baseline cardiopulmonary exercise test.
Resistance training will also be included in each session
consisting of arm, leg, and thoracic exercises, including
dumbbell or weight training depending, on the patient’s
condition and exercise capacity. Clinical and trainingTable 1 Study population: inclusion and exclusion criteria
Inclusion criteria:
Between 18 and 75-years-old
Acute myocardial infarction (according to the universal definition
of myocardial infarction [16])
Both ST elevation and non-ST elevation myocardial infarction
One month since discharge
Left ventricular ejection fraction >30%
Able to exercise
Exclusion criteria
Moderate or severe valvular disease
Atrial fibrillation
Uncontrolled atrial or ventricular tachyarrhythmias
Exercise-induced myocardial ischemia
Pericardial disease
Moderate or severe chronic lung disease (vital capacity and/or forced
expiratory volume in 1 second <80% of age-dependent predicted value)
Severe renal disease or dysfunction (creatinine clearance
<30 mL/min, calculated by the Cockcroft-Gault formula)
Anaemia (hemoglobin <12 g/dL)parameters will be monitored throughout the exercise
including arterial blood pressure, heart rate, glycaemia
(in diabetic patients), and training level intensity. Fa-
tigue will be monitored using the Borg scale.
Patients randomized to the control group will receive
standard of care, with regular appointments with the car-
diologist, optimized medication, and recommendations on
healthy lifestyle.
Measurements: the echocardiographic evaluation protocol
A single experienced cardiologist, blinded to the patient
assignment group, will perform all echocardiographic
studies using an ultrasound system (iE33, Philips Med-
ical Solutions, Best, The Netherlands) equipped with an
S5-1 and X5-1 transducer. Cardiac chamber dimensions,
volumes, and left ventricular mass will be measured ac-
cording to current recommendations and indexed to body
surface area [17]. Mitral inflow velocities will be accessed
using pulsed-wave Doppler in the apical four-chamber
view, placed between the tips of the mitral leaflets and vel-
ocities recorded at end-expiration. Tissue Doppler veloci-
ties will also be acquired at end-expiration, in the apical
four-chamber view, with the sample positioned at the sep-
tal and lateral mitral annulus for determination of systolic
(S’), early diastolic (E’), and late diastolic (A’) velocities.
Pulsed wave Doppler velocities at the upper right pulmon-
ary vein will also be recorded to calculate the Ard-Ad rela-
tion: the time difference between the duration of the atrial
reverse wave of the pulmonary flow (Ard) and the mitral
A-wave duration. For all parameters, the average of three
consecutive heart beats will be recorded.
Left ventricle diastolic function will be evaluated accord-
ing to the EAE/ASE consensus guidelines on diastolic func-
tion evaluation [18], which include the determination of
peak early (E) and late (A) diastolic mitral inflow velocities,
deceleration time of early left ventricular filling (DT), E/A
ratio, isovolumetric relaxation time (IVRT), myocardial
early diastolic velocities at the septal and lateral side of mi-
tral annulus (E’ septal, E’ lateral, and E’ mean), E/E’ ratio
(including septal, lateral, and mean E/E’) and Ard-Ad rela-
tion. Moreover, using the consensus criteria [18], patients
will be categorized in DD grades: normal diastolic func-
tion, grade I (mild DD), grade II (moderate DD), and
grade III (severe DD), by two blinded independent cardiol-
ogists. In case of discordance, each case will be discussed
individually.
Left ventricle systolic function will be evaluated by cal-
culation of biplane ejection fraction (Simpson’s rule) and
determination of systolic velocities at the septal and lateral
side of mitral annulus by tissue Doppler (S’ septal and S’
lateral). It is known that, compared to ejection fraction, S’
velocities are more sensitive parameters for global and
regional systolic function evaluation after myocardial
infarction [19].
Fontes-Carvalho et al. Trials  (2015) 16:90 Page 4 of 6Measurements: cardiopulmonary exercise testing
At the beginning and end of the study protocol, patients
will be submitted to symptom-limited cardiopulmonary
exercise testing on a treadmill, using the modified Bruce
protocol (Cardiovit CS-200 Ergo Spiro; Schiller, Baar,
Switzerland). Expired gases will be continuously collected
throughout exercise and analyzed for ventilatory volume
(VE) and for oxygen (O2) and carbon dioxide (CO2) con-
tent, using dedicated analyzers. Standard spirometry (forced
expiratory volume in one second (FEV1) and forced vital
capacity (FVC)) will also be performed before the exercise
test. Equipment calibration and all measurements will be
done according to the recommendations of the American
Thoracic Society and American College of Chest Physicians
[20]. The following variables will be calculated: peak oxygen
consumption (pVO2), measured in milliliter per kilogram
per minute (mL/Kg/min); peak respiratory exchange ratio,
defined by the ratio of CO2 production to O2 consumption
at peak effort; oxygen consumption at anaerobic threshold
(AT), defined as the point at which CO2 production in-
creases disproportionately in relation to O2 consumption,
obtained from a graph plotting O2 consumption against
CO2 production; and total exercise duration (seconds). It
is known that cardiopulmonary exercise testing with O2
consumption measurement provides the most accurate,
reliable, and reproducible measurements of exercise cap-
acity [21]. We will assess exercise capacity mainly by
measuring pVO2, which is considered the gold standard
parameter for functional capacity assessment [22]. How-
ever, we will also evaluate submaximal exercise capacity
by determination of the ventilatory AT that has the advan-
tage of being relatively effort independent [21].
Measurements: clinical, analytical, and anthropometric data
At baseline and at the end of the study protocol all pa-
tients will be submitted to a clinical evaluation performed
by a cardiologist, a blood sample, and detailed anthropo-
metric evaluation. The clinical evaluation will include an
interview, review of medical registries, and a physical
examination to collect data on cardiovascular risk factors,
previous medical history, medication use or change since
last evaluation, symptoms of angina, and New York Heart
Association functional status (NYHA class).
The anthropometric evaluation will include the measure-
ment of height, weight, waist circumference, and hip cir-
cumference. Body mass index ((BMI) weight/height2 in
kg/m2) will be calculated for each subject. Waist circumfer-
ence will be measured at the midpoint between the iliac
crest and the lower rib margins, measured in the midaxil-
lary line. Body composition will be assessed by bioelectrical
impedance analysis (Tanita Inner Scan BC-522; Tanita,
Tokyo, Japan) to determine body fat percentage (%).
A fasting venous blood sample will be obtained immedi-
ately before and after the study for measurement of glucose,total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyc-
erides, high-sensitivity C-reactive protein, and N-terminal
pro-BNP. Insulin resistance will be assessed using the
Homeostasis Model Assessment of Insulin Resistance
(HOMA-IR) score.Study endpoints
The primary endpoint will be the change in E’ lateral
velocity after the eight-week exercise training program.
Secondary endpoints will be other echocardiographic pa-
rameters of left ventricular diastolic and systolic func-
tion, metabolic and inflammation biomarkers, functional
capacity, and anthropometric measurements, as detailed
in Study primary and secondary endpoints:Primary endpoint
E’ lateral velocity: change between baseline and follow-up
Secondary endpoints
– Left ventricular diastolic function parameters:
E’ septal velocity; E/E’ septal, lateral and mean ratio;
E/A ratio; E-wave deceleration time; isovolumetric
relaxation time; diastolic dysfunction grades according to
the ASE/ESE consensus
– Systolic function parameters:
Ejection fraction, S’ lateral and septal velocities
– Functional capacity parameters:
Peak VO2; VO2 at anaerobic threshold; exercise
duration
– Metabolic biomarkers:
Insulin and glucose plasma levels; insulin resistance
(Homeostasis Model Assessment);
– Cardiovascular biomarkers:
N-terminal pro-BNP and high sensitivity C-reactive
protein
– Anthropometric parameters:
Weight, body mass index, waist and hip perimeter, fat
mass percentage by bioimpedance analysisStatistical analysis and sample size calculation
The analysis of the primary endpoint will be performed on
an intention-to-treat basis by repeated-measures analysis
of covariance (ANCOVA), including the following vari-
ables: baseline E′ velocity, age, mean arterial pressure,
treatment group, gender, and baseline degree of DD.
To calculate the sample size we used as a reference the
data from the study of Edelman et al., which tested the ef-
fect of exercise training in patients with heart failure with
preserved ejection fraction [12]. Assuming a standard de-
viation of the change in E’ velocity from baseline to
follow-up of 1.5 cm/s in each group, we estimated that, to
detect a difference of 1 cm/s in the change of E’ velocity
between treatment groups, a minimum of 48 patients
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5% and a statistical power of 90% will be defined.
Ethical and legal issues
Informed consent will be obtained from all patients prior
to study beginning. The ethics review board (Comissão
de Ética do Centro Hospitalar de Vila Nova de Gaia) ap-
proved the study protocol (reference: 627/10). The study
conforms to the principles outlined in the Declaration of
Helsinki (1975) and has been registered at ClinicalTrials.
gov (reference: NCT02224495).
Discussion
Until now no therapy or intervention has proved to sig-
nificantly improve diastolic function and to change the
prognosis of diastolic heart failure [9,23]. Structured pro-
grams of exercise training can have several benefits in
metabolic, muscular, pulmonary, and cardiovascular pa-
rameters. Data from experimental studies also suggest
that exercise training can improve systolic and diastolic
function and promote favorable myocardial remodelling
[10,11]. In this study, we aim to evaluate the impact of
a structured program of endurance plus resistance
training on cardiac function in patients who have had
an AMI. Theoretically, the benefits of exercise training
can depend on clinical context and on the type, intensity,
and duration of exercise [24,25]. In this study, we will test
a combination of endurance plus resistance training dur-
ing eight-weeks, encompassing three sessions per week.
The combination of endurance and strength training is
important because strength training is useful to accelerate
the improvements in skeletal muscle bulk and function.
The protocol that will be used is similar to the one applied
by Edelmann et al., that also tested the effect of exercise
training on diastolic function in patients with heart failure
with preserved ejection fraction [12].
Cardiac function will be assessed by echocardiography
using both traditional parameters and those derived from
tissue Doppler imaging. Diastolic function will be evalu-
ated according to the latest consensus criteria between the
American Society of Echocardiography and the European
Association of Echocardiography. For the evaluation of left
ventricular diastolic function it is known that traditional
parameters, based on mitral inflow and pulmonary vein
flow velocities (such as the E/A ratio, DT, or Ard-Ad), are
markedly influenced by loading conditions, left ventricular
compliance, and left atrium function [18,23,26,27]. There-
fore the primary endpoint in this study will be the E’
velocity, determined by tissue Doppler analysis. Several
studies have shown that E’ velocity is closely related with
left ventricular relaxation assessed invasively by tau (the
time constant of isovolumic pressure decline) [28,29]. We
will also evaluate the E/E’ ratio, which is a diastolic func-
tion parameter derived from tissue Doppler that closelyreflects left ventricular filling pressures determined inva-
sively [18,30]. Systolic function will be evaluated by ejec-
tion fraction and by systolic mitral annulus velocities
(S’ velocity) from tissue Doppler. It is known that ejection
fraction is both preload- and afterload-dependent, and has
several limitations in the assessment of global left ventricle
systolic function. On the contrary, the evaluation of S’
velocities is more sensitive in the evaluation of global and
regional systolic function after myocardial infarction [19].
Trial status
Recruitment for the study has finished; 188 patients have
been included as of February 2015.
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